Blog

Scientists have created an injectable gel that can remain inside arthritic joints for weeks, slowly releasing medication while also improving lubrication. The approach could make it easier to deliver disease-modifying drugs directly where they are needed while limiting exposure elsewhere in the body...

Extracellular vesicles from menstrual blood stem cells promoted cartilage production in human tissues, offering a potential non-invasively sourced therapy for osteoarthritis.

The 4DCARE project is advancing the treatment of joint injuries by manufacturing functional living tissues capable of regenerating cartilaginous tissue.

In this episode of "Tomorrow`s Cure," orthopedic researchers from Mayo Clinic and Mass General Brigham discuss RECLAIM, an investigational regenerative medicine approach designed to help restore damaged cartilage.

A team in the Department of Chemical and Environmental Engineering at the EHU-University of the Basque Country and which is part of the BIOMAT group has developed structures for cartilage regeneration based on cellulose, gelatin and soy proteins with promising mechanical and biological properties.

Owing to the lack of blood vessels and nerves and the limited number of chondrocytes in articular cartilage, cartilage repair has long been a topic of interest and a clinical challenge worldwide

Dedifferentiated liposarcoma (DDLS) is a rare and aggressive soft tissue cancer with few effective treatment options. But now a clinical trial led by doctors from Memorial Sloan Kettering Cancer Center (MSK) has found that abemaciclib (Verzenio®) - a drug already approved for certain breast cancers...

Sarcomas are cancers that occur in bone or soft tissue, such as muscles and fat. These cancers are rare and diverse, with more than 150 different variations.

Spira notes that delayed sarcoma diagnoses are not typically the result of physician error but rather just due to the nature of the condition. Because sarcomas arise in muscle and soft tissue, early symptoms can resemble a common strain or minor injury, leading patients to be reassured or treated co...

Afami-cel dramatically shrank sarcoma tumors in almost half of patients participating in a clinical trial, led by Memorial Sloan Kettering Cancer Center (MSK) sarcoma specialist and immunotherapy expert Sandra D’Angelo, MD.